Henry Schein CEO – Frederick Lowery (Age – 54)

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, named Frederick M. (Fred) Lowery as its new CEO effective March 2, 2026. Lowery succeeded the legendary Stanley M. Bergman, who led the company for over 35 years and grew revenue from $225 million to nearly $13 billion. A seasoned healthcare industry executive, Lowery brings more than two decades of leadership experience from Thermo Fisher Scientific, where he oversaw global distribution operations and drove above-market growth across laboratory and bioproduction businesses.

Read on to discover Henry Schein CEO email address, Frederick Lowery net worth in 2026, salary and compensation, career history, education, and more.
Frederick Lowery Henry Schein CEO
Frederick M. Lowery, Chief Executive Officer of Henry Schein, Inc. • Photo: Henry Schein

Frederick Lowery – Quick Facts

Frederick M. Lowery — At a Glance
Full Name Frederick M. (Fred) Lowery
Position Chief Executive Officer & Board Member
Company Henry Schein, Inc. (Nasdaq: HSIC)
Age 54 years (as of 2026)
Education B.S. Mechanical Engineering, Tennessee Tech; M.S. Manufacturing Management, Kettering University
Net Worth (2026 est.) $7–10 Million
Base Salary (2026) $1,250,000
CEO Since March 2, 2026
Predecessor Stanley M. Bergman (CEO 1989–2025)
Previous Role EVP & President, Lab Products & BioProduction, Thermo Fisher Scientific
Email Domain [email protected]
Board Seats DuPont de Nemours (DD), Boston Medical Center

Henry Schein Competitors

Henry Schein operates in the healthcare products distribution industry, serving dental and medical office-based practitioners worldwide. Key competitors include:

  • Patterson Companies (PDCO) – Dental and animal health distribution
  • McKesson Corporation (MCK) – Pharmaceutical and medical supply distribution
  • Cardinal Health (CAH) – Healthcare products and services distribution
  • Benco Dental – Largest privately owned dental distributor in the U.S.
  • Dentsply Sirona (XRAY) – Dental products and technologies manufacturer
  • Envista Holdings (NVST) – Dental products and digital workflows
  • Owens & Minor (OMI) – Healthcare logistics and distribution

Frederick Lowery Net Worth 2026 – Henry Schein CEO Salary

As of 2026, Frederick Lowery’s net worth is estimated at approximately $7–10 million, based on his reported stock holdings in Thermo Fisher Scientific, DuPont, and his new Henry Schein equity grants per SEC filings. According to Benzinga, Lowery held approximately $7.65 million in disclosed stock positions across companies where he has served as an executive or director.

Under his employment agreement with Henry Schein dated January 10, 2026, Lowery receives a substantial compensation package befitting the CEO of a Fortune 500 healthcare company:

Henry Schein CEO Compensation Package (2026)

Component Amount (USD) Notes
Base Salary $1,250,000 Annual
Target Annual Bonus $1,875,000 150% of base salary
Equity Awards (FY2026) $10,000,000 Target grant-date value
Sign-On Cash Bonus $1,184,000 One-time payment
Sign-On Equity (RSUs) $2,500,000 Vesting over 3 years
Relocation Allowance Up to $500,000 Reimbursement
ESTIMATED TOTAL (Year 1) ~$17.3M Including sign-on
Key Insight: Lowery’s bonus metrics for 2026 are weighted 70% on earnings per share and 30% on a strategic scorecard, signaling Henry Schein’s board focus on both profitability and strategic transformation under new leadership.

Predecessor Compensation (Stanley Bergman, FY2024)

For context, outgoing CEO Stanley Bergman earned approximately $11.64 million in total compensation in fiscal year 2024, including a $1.7 million base salary, $7.8 million in stock awards, and $1.8 million in performance incentives.

Henry Schein Net Worth 2026 – Is Henry Schein Profitable?

Yes, Henry Schein is a profitable Fortune 500 and S&P 500 company. The company reported solid financial results for fiscal year 2024 with steady revenue growth and improving cash flows.

Henry Schein Financial Summary

Metric FY2024 FY2023 YoY Change
Revenue $12.67B $12.33B ▲ 2.7%
Q4 2024 Revenue $3.2B $3.02B ▲ 5.8%
Adjusted EBITDA (Q4) $270M $239M ▲ 13%
Non-GAAP Diluted EPS $4.74 $4.18 ▲ 13.4%
Operating Cash Flow $848M $500M ▲ 69.6%
Market Capitalization ~$9.3B ~$8.0B ▲ ~16%
Global Operations 32+ countries 32 countries
Nasdaq Ticker HSIC
2025 Guidance: Henry Schein projects total sales growth of 2% to 4% over 2024, with non-GAAP diluted EPS expected at $4.80–$4.94 and mid-single-digit Adjusted EBITDA growth.

Henry Schein CEO Email Address | Frederick Lowery Contact

Below are the official contact details for Henry Schein CEO Frederick Lowery and the company:

Contact Information
CEO Email (format) [email protected]
Investor Relations investor.henryschein.com
Corporate Communications [email protected]
Corporate HQ 135 Duryea Road, Melville, NY 11747
Phone (631) 843-5500
Website www.henryschein.com

Career & Education – Company, University, & College

Frederick Lowery built an impressive career spanning more than 25 years across multiple Fortune 500 companies in healthcare, manufacturing, and distribution. Below is his complete career timeline:

Frederick Lowery Career Timeline

Period Role Company
Early career Leadership roles in engineering, procurement & operations General Motors / Delphi Automotive
Mid-career Executive roles in marketing & business development Maytag Corporation
2005–2006 Head of Operations, Molecular Bio Products Fisher Scientific International
2006–2010 VP & GM, Chromatography Consumables & Specialty Glass Thermo Fisher Scientific
2010–2014 VP & GM, Life Science Research → President, Laboratory Consumables Thermo Fisher Scientific
2014–2024 SVP & President, Laboratory Products; Sr. Operating Officer, Life Sciences Solutions Thermo Fisher Scientific
Apr 2024–2025 EVP & President, Laboratory Products & BioProduction Thermo Fisher Scientific
Mar 2026–Present Chief Executive Officer & Board Member Henry Schein, Inc.

Lowery began his career at General Motors and Delphi Automotive Systems, working in product engineering, procurement, and operations. He then moved to Maytag Corporation, where he took on executive roles in marketing and business development.

In 2005, he joined Fisher Scientific International as head of operations for the Molecular Bio Products business. When Fisher Scientific merged with Thermo Electron in 2006 to form Thermo Fisher Scientific, Lowery was named VP and General Manager of the Chromatography Consumables and Specialty Glass business.

Over the next 18 years at Thermo Fisher, Lowery steadily rose through the ranks, eventually overseeing businesses representing more than half of the company’s revenue. In his final role as EVP and President of Laboratory Products and BioProduction, he led the company’s global distribution operations to above-market performance and managed a vast portfolio of laboratory equipment and supplies.

Education

University Degree / Program
Tennessee Technological University Bachelor of Science in Mechanical Engineering (1994)
Kettering University Master of Science in Manufacturing Management
University campus - Frederick Lowery earned his BS in Mechanical Engineering from Tennessee Tech
Frederick Lowery graduated from Tennessee Technological University with a B.S. in Mechanical Engineering in 1994. He attended on a football scholarship after graduating from Austin-East High School in Knoxville, Tennessee. Photo: Unsplash

Lowery is a native of Knoxville, Tennessee, where he graduated from Austin-East High School in 1988. He attended Tennessee Technological University on a football scholarship and earned his Bachelor of Science in Mechanical Engineering in 1994. He later obtained a Master of Science in Manufacturing Management from Kettering University (formerly GMI Engineering & Management Institute) in Flint, Michigan.

Lowery maintains strong ties to his alma mater. He serves on the Tennessee Tech Board of Trustees and the university’s Foundation Board, and he established the Fred M. Lowery Award Scholarship to encourage students from Austin-East High School to attend Tennessee Tech.

Frederick Lowery Wiki – Age, Family, & More

Henry Schein CEO Frederick M. Lowery (age 54) is originally from Knoxville, Tennessee, and has been based in the greater Boston, Massachusetts area during his tenure at Thermo Fisher Scientific, headquartered in Waltham, MA. He is expected to relocate to the Long Island, New York area near Henry Schein’s headquarters in Melville.

Lowery keeps his personal family life private, and specific details about his spouse and children are not publicly disclosed. He is known for his deep commitment to community service, diversity, equity and inclusion, and STEM education.

Notable Achievements & Community Leadership

  • 50 Most Influential Business Leaders of Color – Honored by the Charles River Regional Chamber of Commerce
  • DuPont Board of Directors – Independent Director since June 2019
  • Boston Medical Center Board – Board member, supporting healthcare access
  • New Commonwealth Racial Equity and Social Justice Fund – Founder
  • The JUST Project – Founder, social impact initiative
  • Lowery Family Fund – Supports community service, philanthropy, and the arts
  • Thermo Fisher $25M Impact Investment – Spearheaded investment into Black-led financial institutions supporting Black-owned businesses
  • Tennessee Tech Board of Trustees – Named in 2020; endowed three scholarships at the university
  • NACD New England Chapter – Board of Directors member
Dental healthcare equipment and products - Henry Schein serves office-based dental and medical practitioners
Henry Schein is the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, serving over 1 million customers globally. Photo: Unsplash

About Henry Schein

Henry Schein, Inc. is an American Fortune 500 and S&P 500 healthcare solutions company headquartered in Melville, New York. Founded in 1932 as a small pharmacy in Queens, New York, the company has grown into the world’s largest provider of healthcare products and services to office-based dental and medical practitioners, with operations in 32+ countries and nearly $13 billion in annual revenue.

Business Segment Description
Dental Distribution Equipment, supplies, and digital technology for dental practices
Medical Distribution Supplies and equipment for physician offices and urgent care
Technology & Value-Added Services Practice management software, electronic health records, and financial services
Henry Schein One Dental practice management and patient engagement platform

Henry Schein trades on the Nasdaq under the ticker symbol HSIC. The company serves over 1 million healthcare professionals globally and employs approximately 22,000 Team Schein Members.

Frequently Asked Questions (FAQ)

Who is the current CEO of Henry Schein?

Frederick M. (Fred) Lowery is the current CEO of Henry Schein, Inc. He was appointed Chief Executive Officer effective March 2, 2026, succeeding Stanley M. Bergman who led the company for over 35 years.

What is Frederick Lowery’s net worth in 2026?

As of 2026, Frederick Lowery’s net worth is estimated at approximately $7–10 million, based on his disclosed stock holdings across Thermo Fisher Scientific, DuPont, and his new Henry Schein equity grants.

What is Henry Schein CEO’s salary?

Frederick Lowery’s base salary at Henry Schein is $1,250,000, with a target annual bonus of 150% of base ($1,875,000) and equity awards with a target grant-date value of $10 million. His total estimated Year 1 compensation is approximately $17.3 million including sign-on bonuses.

What is Henry Schein CEO’s email address?

Henry Schein CEO Frederick Lowery can be reached at [email protected] (based on the company’s email format). The corporate headquarters phone number is (631) 843-5500 and the company website is www.henryschein.com.

What did Frederick Lowery do before Henry Schein?

Before becoming Henry Schein CEO, Frederick Lowery spent nearly 20 years at Thermo Fisher Scientific, most recently serving as EVP and President of Laboratory Products and BioProduction. Earlier in his career, he held leadership roles at General Motors, Delphi Automotive, and Maytag Corporation.

Who was CEO of Henry Schein before Frederick Lowery?

Stanley M. Bergman served as Henry Schein’s CEO from 1989 to 2025, growing the company’s revenue from $225 million to nearly $13 billion — a compound annual growth rate of approximately 17.5%. Bergman remains as Chairman of the Board.

Is Henry Schein in the S&P 500?

Yes. Henry Schein (Nasdaq: HSIC) is both an S&P 500 and Fortune 500 company, with a market capitalization of approximately $9.3 billion as of early 2026.

Article last updated:March 2026March 4, 2026

Disclaimer: All information presented in this article has been compiled from publicly available sources, including SEC filings, official company press releases, and reputable news outlets. This content is provided for informational purposes only and does not constitute financial or investment advice. Net worth figures are estimates and may vary by source.